glp-1 prescriptions growth q1 2025 Trends GLP-1 Agonists Weight Loss Drugs
Description
R.DeYoungM
Smits and colleagues, Frontiers in Endocrinology , 2021.) Because the drug slows the stomach, retained food can raise aspiration risk during surgery or a scope, so many guidelines now advise pausing it before procedures, a decision your clinician makes
That third arm is thought to drive its unusually large weight effect
Pharmacological inhibition of the PI3K/mTOR pathway abolished such effects, suggesting that the metabolic actions of GLP-1 depend on mTOR activity
Diabetes Care 39, 222230
Genetic predispositions can provide context for expected response patterns
